Entry Detail



General Information

Database ID:exR0270116
RNA Name:hsa-miR-5100
RNA Type:miRNA
Chromosome:chr10
Starnd:+
Coordinate:
Start Site(bp):42997630End Site(bp):42997651
External Links:hsa-miR-5100



Disease Information

Disease Name:Multiple Sclerosis
Disease Category:Nervous System Diseases
MeSH ID:D009103
Type:Diseases Category/Nervous System Diseases
Alias:Sclerosis, Multiple//Sclerosis, Disseminated//Disseminated Sclerosis//MS (Multiple Sclerosis)//Multiple Sclerosis, Acute Fulminating



Expression Detail

GEO ID:GSE140106
Description:Serum exosome microRNAs predict multiple sclerosis disease activity after fingolimod treatment
Experimental Design:Fingolimod treatment
Case Disease Type:Multiple Sclerosis
Case Disease SubType:NA
Case Sample:Fingolimod treated Multiple Sclerosis
Control Sample:Untreated
Number of Case:27
Number of Control:27
Number of Samples:54





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
SNU13
chr22
41673933
41690504
-
GHITM
chr10
84139509
84153568
+
AGRN
chr1
1020120
1056118
+
PRRC2B
chr9
131373636
131500197
+
HNRNPH1
chr5
179614178
179634784
-
GTF3C4
chr9
132670035
132694953
+
PPCDC
chr15
75023586
75117462
+
SLC35B1
chr17
49700934
49709014
-
SRP72
chr4
56467617
56503681
+
SRPK1
chr6
35832966
35921342
-
CHPF
chr2
219538948
219543809
-
NOP14
chr4
2937933
2963406
-
SLC52A2
chr8
144354135
144361272
+
THOP1
chr19
2785503
2815807
+
MACF1
chr1
39081316
39487177
+
CPTP
chr1
1324756
1328896
+
UBR4
chr1
19074510
19210266
-
ZNF136
chr19
12163064
12189871
+
HCN1
chr5
45254948
45696498
-
NUP93
chr16
56730118
56850286
+
KCTD2
chr17
75032575
75065889
+
NIN
chr14
50719763
50831121
-
KDSR
chr18
63327726
63367228
-
ATP1A1
chr1
116372668
116410261
+
PRMT6
chr1
107056674
107067636
+
FLNA
chrX
154348524
154374638
-
NUP107
chr12
68686951
68745809
+
P4HTM
chr3
48989889
49007153
+
VSIG10
chr12
118063593
118136026
-
WASF2
chr1
27404230
27490167
-
miRNA targets:NA
circRNA targets:NA
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
POLR2J4
chr7
43940895
44019175
-
SNHG3
chr1
28505980
28510892
+
AC008738.2
chr19
33305036
33309387
+
Display:



Experiment Detail

GEO ID:GSE140106
Sample Source:Blood
Source Fraction:Exosome
Platform:GPL11154
Method:NGS
Num of detected RNA Type:1
Num of detected RNAs of this Type:1907
Sample treatment protocol:Exosomes were isolated from 1 mL RNase A (37 °C for 10 min; 100 ng/ml; Qiagen, Australia) treated serum, by size exclusion chromatography (qEV iZONE Science).
RNA Extract protocol:Serum exosomes were processed for RNA extraction using the Plasma/Serum Circulating & Exosomal RNA Purification Mini Kit (Norgen Biotek, Cat. 51000) according to the manufacturer's protocol.
RNA library preparation protocol:Exosome RNA sequencing libraries were then constructed using the NEBNext Multiplex Small RNA Library Prep Kit for Illumina (BioLabs, New England) according to the manufacturer's instructions.



Reference

PMID:31721043
Title:Serum Exosome MicroRNAs Predict Multiple Sclerosis Disease Activity after Fingolimod Treatment
Author:Ebrahimkhani S, Beadnall HN, Wang C, Suter CM, Barnett MH, Buckland ME, Vafaee F
Journal:Mol Neurobiol. 2020 Feb;57(2):1245-1258.
Description:we sought the possible utility of serum exosome microRNAs as biomarkers for disease activity in multiple sclerosis patients in response to fingolimod therapy.